Insider · CIK 0001272247

HAUGHEY THOMAS

Reports to the SEC for 2 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001272247

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-08	ANIPANI PHARMACEUTICALS INCS Sale	Director	SSale	−2,000 sh	$80.88	−$162K	38,878
2026-05-21	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+4,357 sh	—	—	40,878
2025-08-12	ANIPANI PHARMACEUTICALS INCS Sale	Director	SSale	−19.3K sh	$85.93	−$1.66M	36,521
2025-05-22	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+4,336 sh	—	—	55,862
2024-05-21	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+4,410 sh	—	—	51,526
2023-05-23	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+6,865 sh	—	—	47,116
2022-04-27	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+10K sh	—	—	40,251
2021-12-06	ANIPANI PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,500 sh	$39.38	+$98.5K	30,202
2021-03-23	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+9,292 sh	—	—	27,702
2020-04-10	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+7,119 sh	—	—	18,410
2020-03-04	ANIPANI PHARMACEUTICALS INCP Purchase	Director	PPurchase	+3,000 sh	$45.05	+$135K	11,291
2020-03-03	ANIPANI PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,000 sh	$45.18	+$90.4K	8,291
2019-05-15	ANIPANI PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,500 sh	$69.30	+$173K	6,291
2019-03-28	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+1,991 sh	—	—	3,791
2019-03-28	ANIPANI PHARMACEUTICALS INC · Stock OptionsA Award	Director	AAward	+2,409 sh	—	—	2,409
2018-06-06	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+1,800 sh	—	—	1,800
2018-06-06	ANIPANI PHARMACEUTICALS INC · Stock OptionsA Award	Director	AAward	+2,225 sh	—	—	2,225
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.D Disposition to Issuer	Director, President	DDisposition to Issuer	−69.6K sh	$50.00	−$3.48M	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.D Disposition to Issuer	Director, President	DDisposition to Issuer	−900 sh	$50.00	−$45K	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Performance Stock UnitsD Disposition to Issuer	Director, President	DDisposition to Issuer	−25.4K sh	$50.00	−$1.27M	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Restricted Stock UnitsD Disposition to Issuer	Director, President	DDisposition to Issuer	−25.4K sh	$50.00	−$1.27M	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−15K sh	$7.86	−$118K	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−7,496 sh	$16.38	−$123K	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−13.2K sh	$25.73	−$340K	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−34.3K sh	$39.01	−$1.34M	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−44.9K sh	$36.94	−$1.66M	8,673
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−8,673 sh	—	—	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−25.3K sh	—	—	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−17.8K sh	—	—	0
2012-09-28	PAR PHARMACEUTICAL COMPANIES, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President	DDisposition to Issuer	−50.9K sh	—	—	0
2012-01-11	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	Director, President	FTax Payment	−1,017 sh	$35.65	−$36.3K	69,648
2012-01-06	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	Director, President	FTax Payment	−744 sh	$34.01	−$25.3K	70,665
2012-01-05	PAR PHARMACEUTICAL COMPANIES, INC.Restricted Stock UnitsA Award	Director, President	AAward	+25.4K sh	—	—	25,438
2012-01-05	PAR PHARMACEUTICAL COMPANIES, INC.Common Stock, Option to BuyA Award	Director, President	AAward	+50.9K sh	—	—	50,875
2012-01-05	PAR PHARMACEUTICAL COMPANIES, INC.Performance Stock UnitsA Award	Director, President	AAward	+25.4K sh	—	—	25,438
2012-01-04	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	Director, President	FTax Payment	−1,057 sh	$32.17	−$34K	71,409
2011-11-21	PAR PHARMACEUTICAL COMPANIES, INC.F Tax Payment	Director, President	FTax Payment	−6,589 sh	$29.56	−$195K	72,466
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.M Exercise/Conversion	Director, President	MExercise/Conversion	+26.8K sh	$13.06	+$350K	105,855
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−2,700 sh	$35.45	−$95.7K	103,155
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−2,493 sh	$35.46	−$88.4K	100,662
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−2,007 sh	$35.47	−$71.2K	98,655
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−2,100 sh	$35.48	−$74.5K	96,555
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−2,182 sh	$35.49	−$77.4K	94,373
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−1,618 sh	$35.50	−$57.4K	92,755
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−500 sh	$35.51	−$17.8K	92,255
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−700 sh	$35.52	−$24.9K	91,555
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−200 sh	$35.53	−$7,106	91,355
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−100 sh	$35.54	−$3,554	91,255
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−1,100 sh	$35.55	−$39.1K	90,155
2011-05-10	PAR PHARMACEUTICAL COMPANIES, INC.S Sale	Director, President	SSale	−400 sh	$35.57	−$14.2K	89,755

Recent filings

Accepted (ET)
Jun 104
HAUGHEY THOMAS0001272247-26-000004
SEC(opens sec.gov)
Aug 144
HAUGHEY THOMAS0001272247-25-000005
SEC(opens sec.gov)
May 274
HAUGHEY THOMAS0001272247-25-000003
SEC(opens sec.gov)
May 234
HAUGHEY THOMAS0001272247-24-000003
SEC(opens sec.gov)
May 244
HAUGHEY THOMAS0001104659-23-064140
SEC(opens sec.gov)
Apr 294
HAUGHEY THOMAS0001415889-22-004401
SEC(opens sec.gov)
Dec 74
HAUGHEY THOMAS0001415889-21-005743
SEC(opens sec.gov)
Mar 254
HAUGHEY THOMAS0001415889-21-001655
SEC(opens sec.gov)
Apr 144
HAUGHEY THOMAS0001104659-20-046398
SEC(opens sec.gov)
Mar 54
HAUGHEY THOMAS0001104659-20-029791
SEC(opens sec.gov)
May 154
HAUGHEY THOMAS0001144204-19-026615
SEC(opens sec.gov)
Apr 14
HAUGHEY THOMAS0001144204-19-017408
SEC(opens sec.gov)
Jun 84
HAUGHEY THOMAS0001144204-18-033529
SEC(opens sec.gov)
Oct 24
HAUGHEY THOMAS0000878088-12-000057
SEC(opens sec.gov)

Companies

Address

C/O ANI PHARMACEUTICALS, INC. 104 CARNEGIE CENTER, SUITE 300

PRINCETON, NJ, 08540